[go: up one dir, main page]

FR2456325A1 - Procede de preparation de temoins de reference de sang entier ayant une bonne stabilite a long terme, diluant de preconditionnement et milieu a utiliser dans ce but - Google Patents

Procede de preparation de temoins de reference de sang entier ayant une bonne stabilite a long terme, diluant de preconditionnement et milieu a utiliser dans ce but

Info

Publication number
FR2456325A1
FR2456325A1 FR8009978A FR8009978A FR2456325A1 FR 2456325 A1 FR2456325 A1 FR 2456325A1 FR 8009978 A FR8009978 A FR 8009978A FR 8009978 A FR8009978 A FR 8009978A FR 2456325 A1 FR2456325 A1 FR 2456325A1
Authority
FR
France
Prior art keywords
whole blood
term stability
medium
diluent
packaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8009978A
Other languages
English (en)
Other versions
FR2456325B1 (fr
Inventor
Harold Richardson Crews
David Lee Chastain Jr
Stephen Lawrence Ledis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coulter Electronics Inc
Original Assignee
Coulter Electronics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coulter Electronics Inc filed Critical Coulter Electronics Inc
Publication of FR2456325A1 publication Critical patent/FR2456325A1/fr
Application granted granted Critical
Publication of FR2456325B1 publication Critical patent/FR2456325B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'INVENTION SE RAPPORTE A UN MILIEU DE PREPARATION DE TEMOINS DE REFERENCE DE SANG ENTIER AYANT UNE STABILITE A LONG TERME POUR DES DETERMINATIONS DE SANG ENTIER. SELON L'INVENTION, UNE SOLUTION AQUEUSE CONTIENT LES COMPOSANTS QUI SUIVENT: DU LACTOSE, AU MOINS UN FONGICIDE, AU MOINS UN ANTIBIOTIQUE, AU MOINS UN PRODUIT CHIMIQUE QUI MODIFIE LES MEMBRANES DES GLOBULES ROUGES ET QUI EST CHOISI PARMI LES SELS DE BILE ET LES DERIVES DE L'ACIDE CHOLIQUE, LES COMPOSES DE PHENOTHIAZINE AYANT DES PROPRIETES ANTIHISTAMINIQUES ET LES DERIVES DE L'ESTER DE L'ACIDE 4-AMINOBENZOIQUE ET LEURS SELS AYANT DES PROPRIETES ANESTHESIQUES LOCALES, AINSI QUE DE L'ALBUMINE DE BOEUF. L'INVENTION S'APPLIQUE NOTAMMENT AUX DISPOSITIFS DE COMPTAGE UTILISANT DES MOYENS ELECTRONIQUES.
FR8009978A 1979-05-07 1980-05-05 Procede de preparation de temoins de reference de sang entier ayant une bonne stabilite a long terme, diluant de preconditionnement et milieu a utiliser dans ce but Granted FR2456325A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,794 US4299726A (en) 1979-05-07 1979-05-07 Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor

Publications (2)

Publication Number Publication Date
FR2456325A1 true FR2456325A1 (fr) 1980-12-05
FR2456325B1 FR2456325B1 (fr) 1985-05-10

Family

ID=21890689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8009978A Granted FR2456325A1 (fr) 1979-05-07 1980-05-05 Procede de preparation de temoins de reference de sang entier ayant une bonne stabilite a long terme, diluant de preconditionnement et milieu a utiliser dans ce but

Country Status (7)

Country Link
US (1) US4299726A (fr)
JP (1) JPS55151265A (fr)
CA (1) CA1141634A (fr)
DE (1) DE3017152A1 (fr)
FR (1) FR2456325A1 (fr)
GB (1) GB2049929B (fr)
HK (1) HK10486A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2484649A1 (fr) * 1980-06-16 1981-12-18 Coulter Electronics Procede pour la determination differentielle des populations de lymphoides et myeloides des leucocytes ainsi que pour mesurer les valeurs d'hemogramme, diluant isotonique a usages multiples et procede pour la determination des leucocytes et de l'hemoglobine dans le sang

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389490A (en) * 1981-05-29 1983-06-21 Coulter Electronics, Inc. Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; and diluents thereof
US4405719A (en) * 1981-05-29 1983-09-20 Coulter Electronics, Inc. Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; diluents therefor; and combination stabilization procedures
US5045472A (en) * 1981-06-26 1991-09-03 Technicon Instruments Corporation Reagent mixture and composition for treating red blood cells to effect sphering
US4906561A (en) * 1981-09-14 1990-03-06 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
US4668618A (en) * 1981-09-14 1987-05-26 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
US4489162A (en) * 1981-12-21 1984-12-18 American Hospital Supply Corporation Fresh blood (unfixed) hematology control
US4528274A (en) * 1982-07-06 1985-07-09 Coulter Electronics, Inc. Multi-purpose blood diluent and lysing agent for differential determination of lymphoid-myeloid population of leukocytes
DE3225408A1 (de) * 1982-07-07 1984-01-12 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Waessrige loesung zum suspendieren und lagern von zellen, insbesondere erythrozyten
DE3238353A1 (de) * 1982-10-15 1984-04-19 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur simultanen quantitativen bestimmung der blutzellen und reagenz hierfuer
US4579824A (en) * 1983-05-18 1986-04-01 Louderback Allan Lee Hematology control
US4663295A (en) * 1983-06-29 1987-05-05 Ciba Corning Diagnostics Corp. Estrogen-progesterone control reagents and methods for making same
EP0130708A1 (fr) * 1983-06-06 1985-01-09 Gilford Instrument Laboratories, Inc. Réactifs de contrôle cliniques stabilisés
DE3329952A1 (de) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg Verfahren zur verringerung einer truebung in kontrollseren
US4595524A (en) * 1984-03-28 1986-06-17 Miles Laboratories, Inc. Two component stain composition for producing a Giemsa blood stain effect
US4704364A (en) * 1984-05-18 1987-11-03 Coulter Electronics, Inc. Hematology control compositions for three populations of leukocytes; and methods for their preparation and use in whole blood control systems
US4858154A (en) * 1986-04-07 1989-08-15 Coulter Electronics, Inc. Interlaboratory quality assurance program
US5008202A (en) * 1988-11-29 1991-04-16 Sequoia Turner Corporation Blood diluent for red blood cell analysis
US5270208A (en) * 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
DE4135404A1 (de) * 1991-10-26 1993-04-29 Boehringer Mannheim Gmbh Stabiles fluessiges kontroll- bzw. eichserum fuer die klinische diagnostik
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
ATE195810T1 (de) * 1992-02-24 2000-09-15 Coulter Corp Hämatologisches kontrollprodukt mit leukozytenanalogen; und methoden zu ihrer herstellung und anwendung
WO1993017329A1 (fr) * 1992-02-24 1993-09-02 Coulter Corporation Milieux de suspension pour composition hematologique et procede d'utilisation
US6362003B1 (en) 1992-02-24 2002-03-26 Coulter Corporation Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
US5385844A (en) * 1993-04-22 1995-01-31 Boehringer Mannheim Corporation Polymer containing control reagents and polymers useful in control reagents
US5888822A (en) 1995-10-04 1999-03-30 Hycor Biomedical Inc. Erythrocyte sedimentation rate control
GB9526676D0 (en) * 1995-12-29 1996-02-28 Shine Thomas A Method for testing a cell suspension
US5895760A (en) * 1997-02-04 1999-04-20 Hycor Biomedical, Inc. Erythrocyte sedimentation rate control
US5811303A (en) * 1997-04-01 1998-09-22 Streck Laboratories, Inc. Quantitative buffy coat control composition
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
US6767904B2 (en) * 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
US6124089A (en) * 1999-04-30 2000-09-26 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US6159682A (en) * 1999-04-30 2000-12-12 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US6225124B1 (en) * 1999-06-02 2001-05-01 Sysmex Corporation Diluting reagent and method compelling time-independent consistency in MCV assay
US6200500B1 (en) 1999-08-20 2001-03-13 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6221668B1 (en) 1999-08-20 2001-04-24 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6531321B1 (en) 2000-09-15 2003-03-11 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US6653137B2 (en) 2001-12-03 2003-11-25 Streck Laboratories Inc. Hematology reference control
US6723563B2 (en) 2001-12-03 2004-04-20 Streck Laboratories Inc. Hematology reference control
US6916662B2 (en) * 2003-01-31 2005-07-12 Abbott Laboratories Performance improvement for hematology analysis
US7198953B2 (en) * 2003-10-12 2007-04-03 Beckman Coulter, Inc. Method of using a reference control composition for measurement of nucleated red blood cells
US7195919B2 (en) * 2003-12-19 2007-03-27 Beckman Coulter, Inc. Hematology controls for reticulocytes and nucleated red blood cells
JP4993603B2 (ja) * 2004-04-07 2012-08-08 ベックマン コールター， インコーポレイテッド 有核赤血球成分を含む参照対照
US7109036B2 (en) * 2004-05-13 2006-09-19 Beckman Coulter, Inc. Hematology reference control containing an immature granulocyte component
US7354767B2 (en) * 2006-03-16 2008-04-08 Beckman Coulter, Inc. Reference control composition containing a nucleated red blood cell component made of non-nucleated blood cells
EP2082224B1 (fr) 2006-11-14 2015-05-13 Beckman Coulter, Inc. Systeme et methode d'utilisation de compositions de controle de linearite en hematologie
CN101451931B (zh) * 2007-12-04 2013-03-27 深圳迈瑞生物医疗电子股份有限公司 血液稀释液及其使用方法
JP6139215B2 (ja) * 2013-03-29 2017-05-31 シーシーアイ株式会社 中性脂肪濃度測定用の標準物質組成物およびその製造方法
EP3371591A4 (fr) 2015-11-02 2018-11-14 Chiranjit Deka Appareil et procédés fondés sur une diffusion de lumière pour l'analyse hématologique à l'aide de seulement trois détecteurs
WO2018048586A1 (fr) * 2016-09-06 2018-03-15 Chiranjit Deka Réactif amélioré et procédé d'identification et d'énumération de basophiles
JP6889535B2 (ja) * 2016-10-05 2021-06-18 デンカ株式会社 赤血球の凝集方法及び分離方法並びに赤血球凝集用試薬

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035733A5 (fr) * 1969-02-25 1970-12-18 Pfizer
FR2297422A1 (fr) * 1975-01-13 1976-08-06 Coulter Diagnostics Inc Diluant a buts multiples pour utilisation dans l'analyse du sang par un appareillage electronique du type coulter
FR2434396A1 (fr) * 1978-08-22 1980-03-21 Coulter Electronics Agent diluant du sang a multiple objet pour emploi dans des instrumentations d'analyse du sang electroniques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2656508A (en) * 1949-08-27 1953-10-20 Wallace H Coulter Means for counting particles suspended in a fluid
US3520316A (en) * 1963-12-12 1970-07-14 Bowles Eng Corp Pressure-to-pressure transducer
US3956477A (en) * 1973-06-08 1976-05-11 Akzona Incorporated Method and erythrocyte preparation for reverse blood grouping
US3873467A (en) * 1974-02-01 1975-03-25 United Medical Lab Inc Hematologic reference control
US3977995A (en) * 1974-10-17 1976-08-31 Baxter Laboratories, Inc. Calibrating fluid for blood cell counting and hemoglobin determination
US3973913A (en) * 1976-01-29 1976-08-10 Louderback Allan Lee Blood control standard

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035733A5 (fr) * 1969-02-25 1970-12-18 Pfizer
FR2297422A1 (fr) * 1975-01-13 1976-08-06 Coulter Diagnostics Inc Diluant a buts multiples pour utilisation dans l'analyse du sang par un appareillage electronique du type coulter
FR2434396A1 (fr) * 1978-08-22 1980-03-21 Coulter Electronics Agent diluant du sang a multiple objet pour emploi dans des instrumentations d'analyse du sang electroniques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2484649A1 (fr) * 1980-06-16 1981-12-18 Coulter Electronics Procede pour la determination differentielle des populations de lymphoides et myeloides des leucocytes ainsi que pour mesurer les valeurs d'hemogramme, diluant isotonique a usages multiples et procede pour la determination des leucocytes et de l'hemoglobine dans le sang

Also Published As

Publication number Publication date
DE3017152C2 (fr) 1990-02-15
DE3017152A1 (de) 1980-11-27
JPS55151265A (en) 1980-11-25
FR2456325B1 (fr) 1985-05-10
US4299726A (en) 1981-11-10
GB2049929A (en) 1980-12-31
GB2049929B (en) 1983-08-03
HK10486A (en) 1986-02-21
JPS6258470B2 (fr) 1987-12-05
CA1141634A (fr) 1983-02-22

Similar Documents

Publication Publication Date Title
FR2456325A1 (fr) Procede de preparation de temoins de reference de sang entier ayant une bonne stabilite a long terme, diluant de preconditionnement et milieu a utiliser dans ce but
Panganamala et al. Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis
US4780456A (en) Pharmaceutical or dietetic composition having a high antiarteriosclerotic activity
Chignard et al. Platelet‐activating factor (PAF‐acether) secretion from platelets: effect of aggregating agents
Heptinstall et al. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups
Suzuki et al. Leukocyte‐endothelial cell adhesive interactions: role of xanthine oxidase‐derived oxidants
Hopkins et al. The influence of thiol-groups in the activity of dehydrogenases
DeLuca et al. Calcium uptake by rat kidney mitochondria
Ziboh Biosynthesis of prostaglandin E2 in human skin: subcellular localization and inhibition by unsaturated fatty acids and anti-inflammatory drugs
Maddipati et al. Characterization of the hydroperoxide-reducing activity of human plasma
Menche et al. Platelets and microtubules: Effect of colchicine and D 2 O on platelet aggregation and release induced by calcium ionophore A23187
Pedersen et al. Physiologically‐Induced Loose Coupling of Brown‐Adipose‐Tissue Mitochondria Correlated to Endogenous Fatty Acids and Adenosine Phosphates
Vergroesen et al. Protection against X-irradiation by Sulphydryl Compounds: II. Studies on the Relation between Chemical Structure and Protective Activity for Tissue Culture Cells
Buchanan et al. Arachidonic acid metabolism and the adhesion of human polymorphonuclear leukocytes to cultured vascular endothelial cells
TW262386B (fr)
Ogletree et al. Arachidonate raises vascular resistance but not permeability in lungs of awake sheep
US5569673A (en) Capsacinoid compounds as proliferation inhibitors
Thomas et al. The influence of glutathione and other thiols on human platelet aggregation
Barrowcliffe et al. The effect of fatty-acid autoxidation products on blood coagulation
DE69905468T2 (de) Sporizide zusammensetzung
Munro et al. Biochemical and pathological changes in rats fed brominated cottonseed oil for 80 days
Harrison et al. The secondary oxidation of some substances of physiological interest
Johnson et al. The relation between the rate of enzymic oxidation and the stereochemical structure of ascorbic acid and its analogues
Shakir et al. Enhanced phospholipase A2 activity in rat plasma, liver, and intestinal mucosa following endotoxin treatment: a possible explanation for the protective effect of indomethacin in endotoxic shock
Segel et al. Amino acid transport in human lymphocytes: distinctions in the enhanced uptake with PHA treatment or amino acid deprivation